Frequently asked questions
The global remote patient monitoring devices market was valued at USD 53.1 Billion in 2022.
The remote patient monitoring devices market is expected to grow at a CAGR of 26.20% between 2023 and 2030, reaching USD 270.71 Billion in 2030.
Blood pressure monitors are the leading segment by product, holding over 43% share in terms of value in 2022.
The diabetes segment governs the demand for remote patient monitoring devices worldwide, holding a massive share of over 80% in 2022.
The cancer segment will post the highest CAGR during the forecast period.
Asia Pacific is fueling the growth of the remote patient monitoring devices industry, with an over one-third share in 2022.
The top players include Honeywell; American Telecare; Roche; Philips Healthcare; Bosch; Biotronik; Intel; Welch Allyn; Health anywhere Inc.; Johnson & Johnson; Covidien Plc.
Numerous advantages of this strategy increase demand for RPM devices by remote patient monitoring devices are the major market drivers.
Difficult for manufacturers and healthcare organizations to ensure compliance with various healthcare regulations; data privacy laws are the major market restraints.
With the huge growth potential in Asia Pacific, Remote monitoring of patient’s vital signs and health parameters is frequently used in telehealth consultations to enable more precise diagnoses, and individualized treatment plans are the major opportunities in the remote patient monitoring devices industry.